Literature DB >> 7810295

Cerebral and cerebellar gangliocytomas: a morphological study of nine cases.

I Felix1, J M Bilbao, S L Asa, F Tyndel, K Kovacs, L E Becker.   

Abstract

Hypothalamic gangliocytomas have been shown to contain immunoreactivity for hypophysiotropic peptides and some have been associated with endocrine dysfunction. Extrahypothalamic gangliocytomas are usually not associated with endocrine abnormalities. We studied nine cerebral or cerebellar gangliocytomas from six men and three women; none of the patients had detectable alterations of endocrine homeostasis. On histological examination, the tumor cells resembled hypothalamic neurons. Electron microscopy disclosed the presence of dense-core vesicles in neuronal cytoplasm and processes resembling Herring bodies, and there were synaptic contacts between tumor cells. All but two tumors contained immunocytochemical positivity for at least one peptide hormone or amine; these included somatostatin, corticotropin-releasing hormone, beta-endorphin, galanin, vasoactive intestinal peptide, calcitonin, serotonin, catecholamines or met-enkephalin. These tumors have been thought to represent neoplasms arising in ectopic autonomic neural tissue. Their morphological features, their similarity to hypothalamic gangliocytomas and the multiple immunoreactivities shown here suggest that they can be regarded as tumors of peptidergic neurons that are widely distributed throughout the central nervous system.

Entities:  

Mesh:

Year:  1994        PMID: 7810295     DOI: 10.1007/bf00293400

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  26 in total

1.  Desmoplastic infantile ganglioglioma: CT and MR features.

Authors:  D S Martin; B Levy; E E Awwad; T Pittman
Journal:  AJNR Am J Neuroradiol       Date:  1991 Nov-Dec       Impact factor: 3.825

2.  MR and CT characteristics of gangliocytoma: a rare cause of epilepsy in children.

Authors:  N R Altman
Journal:  AJNR Am J Neuroradiol       Date:  1988-09       Impact factor: 3.825

3.  Ultrastructural study of a cerebral gangliocytoma.

Authors:  K Kawamoto; Y Yamanouchi; J Suwa; T Kurimoto; H Matsumura
Journal:  Surg Neurol       Date:  1985-11

4.  A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor.

Authors:  S L Asa; B W Scheithauer; J M Bilbao; E Horvath; N Ryan; K Kovacs; R V Randall; E R Laws; W Singer; J A Linfoot
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

5.  Identification of gonadotropin-releasing hormone in neurons of a hypothalamic hamartoma in a boy with precocious puberty.

Authors:  F L Culler; H E James; M L Simon; K L Jones
Journal:  Neurosurgery       Date:  1985-09       Impact factor: 4.654

6.  Hypothalamic neuronal hamartoma and adenohypophyseal neuronal choristoma: their association with growth hormone adenoma of the pituitary gland.

Authors:  B W Scheithauer; K Kovacs; R V Randall; E Horvath; H Okazaki; E R Laws
Journal:  J Neuropathol Exp Neurol       Date:  1983-11       Impact factor: 3.685

7.  The occurrence of catecholamine neurons in a parietal lobe ganglioglioma.

Authors:  K Kawai; H Takahashi; F Ikuta; K Tanimura; Y Honda; H Yamazaki
Journal:  Cancer       Date:  1987-10-01       Impact factor: 6.860

8.  Treatment of sexual precocity by removal of a luteinizing hormone-releasing hormone secreting hamartoma.

Authors:  R A Price; P A Lee; A L Albright; O K Ronnekleiv; J P Gutai
Journal:  JAMA       Date:  1984-05-04       Impact factor: 56.272

9.  Neuroendocrine markers in central nervous system neuronal tumors (gangliocytoma and ganglioglioma).

Authors:  H Takahashi; K Wakabayashi; K Kawai; F Ikuta; R Tanaka; N Takeda; K Washiyama
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

10.  Intracerebral ganglioglioma.

Authors:  B Demierre; F A Stichnoth; A Hori; O Spoerri
Journal:  J Neurosurg       Date:  1986-08       Impact factor: 5.115

View more
  5 in total

1.  Evaluation of Galanin Expression in Colorectal Cancer: An Immunohistochemical and Transcriptomic Study.

Authors:  Iman M Talaat; Nada M Yakout; Ahmed S A Soliman; Thenmozhi Venkatachalam; Arya Vinod; Leen Eldohaji; Vidhya Nair; Amal Hareedy; Alaa Kandil; Wael M Abdel-Rahman; Rifat Hamoudi; Maha Saber-Ayad
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

Review 2.  Central neuronal tumors in childhood: relationship to dysplasia.

Authors:  L E Becker
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 3.  Hypothalamic Endocrine Tumors: An Update.

Authors:  Sylvia L Asa; Ozgur Mete
Journal:  J Clin Med       Date:  2019-10-20       Impact factor: 4.241

Review 4.  The Galaninergic System: A Target for Cancer Treatment.

Authors:  Manuel Lisardo Sánchez; Rafael Coveñas
Journal:  Cancers (Basel)       Date:  2022-08-01       Impact factor: 6.575

5.  Galanin System in Human Glioma and Pituitary Adenoma.

Authors:  Sarah Falkenstetter; Julia Leitner; Susanne M Brunner; Tim N Rieder; Barbara Kofler; Serge Weis
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-24       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.